Safety, Dose Tolerance, Pharmacokinetics, and Pharmacodynamics Study of CPX-POM in Patients With Advanced Solid Tumors
Clinical trial NCT04608045 · COMPLETED
Trial details
- NCT number
- NCT04608045
- Sponsor
- CicloMed LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-19
- Primary completion
- 2023-04-30
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.